Nutex Health Inc.

NUTX Healthcare Medical Care Facilities

Nutex Health Inc.’s revenue for fiscal 2025 (year ended December 2025) was $875.3 million, up 82.4% from fiscal 2024. In the quarter to June 2026, revenue fell 13.6%, EPS grew 424.8%, free cash flow grew 19.4% and total debt fell 1.69%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.

185.95 14.85 −7.40%
Market cap
$1.4B
P/E
7.1×
Fwd P/E
6.3×
Dividend yield
—
F-score
7/9
Altman Z
3.27
Beneish M
−2.54
Dividend safety
41/100
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Piotroski F-Score
— — — 2 6 5 3 5 7 7
P/E ratio
— 70.50 70.50 70.50 70.50 70.50 0.00 0.00 3.19 17.38
Altman Z-Score
— — — — — — (1.33) (0.76) 1.09 3.27
P/S ratio
— 58.05 58.05 58.05 58.05 58.05 5.76 0.53 0.34 1.20
P/FCF ratio
— 144.46 144.46 144.46 144.46 144.46 35.12 0.00 7.74 4.26
Altman Z″-Score (non-manufacturers)
— (20.13) (63.71) (15.95) 5,669.46 6.67 (8.01) (3.09) 1.37 4.62
Beneish M-Score
— — 38.62 (4.33) 1,792.72 4,806.18 (5.05) (3.38) (0.66) (2.54)
P/Operating CF
— 663.75 663.75 663.75 663.75 663.75 280.38 (74.48) 2,987.55 14.88
Dividend Safety Score
— — — — — — — — — 41
P/B ratio
— 328.93 328.93 328.93 328.93 328.93 10.50 1.67 0.86 2.47
EV/Sales
— 58.03 58.03 58.03 58.03 58.03 6.71 1.47 0.87 1.33
EV/EBITDA
— 111.00 111.00 111.00 111.00 111.00 0.00 0.00 2.78 3.92
EV/FCF
— 144.40 144.40 144.40 144.40 144.40 40.89 (44.25) 20.03 4.72
Current Ratio
0.08 0.06 0.29 0.27 0.14 4.09 1.79 1.56 1.90 3.41
Net Debt/EBITDA
(0.09) (0.06) (1.15) (0.19) 0.00 0.67 (0.53) (16.39) 1.71 0.43
Debt/Equity
(0.01) 0.14 (0.72) 1.26 (0.43) 0.81 2.01 3.22 1.59 0.74
ROE
0.00% (33.26%) (218.01%) (3,942.66%) 29,249.21% 139.24% (272.38%) (45.92%) 38.93% 23.13%
ROA
(2,910.02%) 30.32% (50.29%) (199.29%) 3,088.42% 67.17% (102.80%) (11.03%) 9.89% 9.00%
ROIC
0.00% (132.11%) 0.00% (137.79%) 0.00% 34.30% (77.50%) (6.38%) 18.36% 31.34%
Return on Tangible Assets
126.59% (64.61%) 129.95% 216.72% (10,767.11%) 49.43% (339.27%) (40.19%) 24.10% 14.89%
Average Days of Receivables
— 99.12 49.72 26.77 0.02 126.34 97.06 92.52 179.52 135.71
Earnings Yield
— 1.42% 1.42% 1.42% 1.42% 1.42% (33.05%) (38.23%) 31.37% 5.75%
Free Cash Flow Yield
— 0.69% 0.69% 0.69% 0.69% 0.69% 2.85% (6.23%) 12.92% 23.45%
Free Cash Flow per Share
(548.40) (649.64) (42.11) (170.44) 6.45 34.52 8.50 (1.87) 4.10 38.61
Book value per Share
(11,738.80) 2,153.64 (131.35) 76.79 (0.29) 48.45 28.43 17.94 37.03 66.56
Free Cash Flow
(0.27) (0.71) (0.48) (4.12) 25.48 136.51 35.97 (8.24) 20.85 245.60
EV/EBIT
— 116.45 116.45 116.45 116.45 116.45 0.00 0.00 3.20 4.21
Other line items

Show all line items

Columns are period end dates